Aster Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Aster Capital Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$34	–	1238
2025 Q4	$34	Buy	+1	New	+$31	﹤0.01%	1050

Aster Capital Management's RAPT Position: Q1 2026 in Review

Aster Capital Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 1 share — an estimated $34 sold.

Aster Capital Management first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $34 in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Aster Capital Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Aster Capital Management sold 1 RAPT Therapeutics share in Q1 2026, an estimated $34.
Aster Capital Management first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Aster Capital Management's RAPT Therapeutics position peaked at $34 in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.